Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gonadotropin-Releasing Hormone Analogues
1.2.3 Prophylactic Hematin Infusions
1.3 Market by Application
1.3.1 Global Acute Intermittent Porphyria Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Intermittent Porphyria Market Perspective (2018-2033)
2.2 Acute Intermittent Porphyria Growth Trends by Region
2.2.1 Global Acute Intermittent Porphyria Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acute Intermittent Porphyria Historic Market Size by Region (2018-2023)
2.2.3 Acute Intermittent Porphyria Forecasted Market Size by Region (2024-2033)
2.3 Acute Intermittent Porphyria Market Dynamics
2.3.1 Acute Intermittent Porphyria Industry Trends
2.3.2 Acute Intermittent Porphyria Market Drivers
2.3.3 Acute Intermittent Porphyria Market Challenges
2.3.4 Acute Intermittent Porphyria Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Intermittent Porphyria Players by Revenue
3.1.1 Global Top Acute Intermittent Porphyria Players by Revenue (2018-2023)
3.1.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2018-2023)
3.2 Global Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Intermittent Porphyria Revenue
3.4 Global Acute Intermittent Porphyria Market Concentration Ratio
3.4.1 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Intermittent Porphyria Revenue in 2022
3.5 Acute Intermittent Porphyria Key Players Head office and Area Served
3.6 Key Players Acute Intermittent Porphyria Product Solution and Service
3.7 Date of Enter into Acute Intermittent Porphyria Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Intermittent Porphyria Breakdown Data by Type
4.1 Global Acute Intermittent Porphyria Historic Market Size by Type (2018-2023)
4.2 Global Acute Intermittent Porphyria Forecasted Market Size by Type (2024-2033)
5 Acute Intermittent Porphyria Breakdown Data by Application
5.1 Global Acute Intermittent Porphyria Historic Market Size by Application (2018-2023)
5.2 Global Acute Intermittent Porphyria Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acute Intermittent Porphyria Market Size (2018-2033)
6.2 North America Acute Intermittent Porphyria Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acute Intermittent Porphyria Market Size by Country (2018-2023)
6.4 North America Acute Intermittent Porphyria Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Intermittent Porphyria Market Size (2018-2033)
7.2 Europe Acute Intermittent Porphyria Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acute Intermittent Porphyria Market Size by Country (2018-2023)
7.4 Europe Acute Intermittent Porphyria Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Intermittent Porphyria Market Size (2018-2033)
8.2 Asia-Pacific Acute Intermittent Porphyria Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Intermittent Porphyria Market Size (2018-2033)
9.2 Latin America Acute Intermittent Porphyria Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acute Intermittent Porphyria Market Size by Country (2018-2023)
9.4 Latin America Acute Intermittent Porphyria Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Intermittent Porphyria Market Size (2018-2033)
10.2 Middle East & Africa Acute Intermittent Porphyria Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dahaner
11.1.1 Dahaner Company Detail
11.1.2 Dahaner Business Overview
11.1.3 Dahaner Acute Intermittent Porphyria Introduction
11.1.4 Dahaner Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.1.5 Dahaner Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Acute Intermittent Porphyria Introduction
11.2.4 Roche Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Introduction
11.3.4 Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Siemens
11.4.1 Siemens Company Detail
11.4.2 Siemens Business Overview
11.4.3 Siemens Acute Intermittent Porphyria Introduction
11.4.4 Siemens Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.4.5 Siemens Recent Development
11.5 ARKRAY
11.5.1 ARKRAY Company Detail
11.5.2 ARKRAY Business Overview
11.5.3 ARKRAY Acute Intermittent Porphyria Introduction
11.5.4 ARKRAY Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.5.5 ARKRAY Recent Development
11.6 Sysmex Corporation
11.6.1 Sysmex Corporation Company Detail
11.6.2 Sysmex Corporation Business Overview
11.6.3 Sysmex Corporation Acute Intermittent Porphyria Introduction
11.6.4 Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.6.5 Sysmex Corporation Recent Development
11.7 ACON Laboratories
11.7.1 ACON Laboratories Company Detail
11.7.2 ACON Laboratories Business Overview
11.7.3 ACON Laboratories Acute Intermittent Porphyria Introduction
11.7.4 ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2018-2023)
11.7.5 ACON Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Intermittent Porphyria Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gonadotropin-Releasing Hormone Analogues
Table 3. Key Players of Prophylactic Hematin Infusions
Table 4. Global Acute Intermittent Porphyria Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Acute Intermittent Porphyria Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Acute Intermittent Porphyria Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Acute Intermittent Porphyria Market Share by Region (2018-2023)
Table 8. Global Acute Intermittent Porphyria Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Acute Intermittent Porphyria Market Share by Region (2024-2033)
Table 10. Acute Intermittent Porphyria Market Trends
Table 11. Acute Intermittent Porphyria Market Drivers
Table 12. Acute Intermittent Porphyria Market Challenges
Table 13. Acute Intermittent Porphyria Market Restraints
Table 14. Global Acute Intermittent Porphyria Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Acute Intermittent Porphyria Market Share by Players (2018-2023)
Table 16. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria as of 2022)
Table 17. Ranking of Global Top Acute Intermittent Porphyria Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acute Intermittent Porphyria Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Intermittent Porphyria Product Solution and Service
Table 21. Date of Enter into Acute Intermittent Porphyria Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Intermittent Porphyria Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Acute Intermittent Porphyria Revenue Market Share by Type (2018-2023)
Table 25. Global Acute Intermittent Porphyria Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Acute Intermittent Porphyria Revenue Market Share by Type (2024-2033)
Table 27. Global Acute Intermittent Porphyria Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Acute Intermittent Porphyria Revenue Market Share by Application (2018-2023)
Table 29. Global Acute Intermittent Porphyria Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Acute Intermittent Porphyria Revenue Market Share by Application (2024-2033)
Table 31. North America Acute Intermittent Porphyria Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Acute Intermittent Porphyria Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Acute Intermittent Porphyria Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Acute Intermittent Porphyria Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Acute Intermittent Porphyria Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Acute Intermittent Porphyria Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Acute Intermittent Porphyria Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Acute Intermittent Porphyria Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Acute Intermittent Porphyria Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Acute Intermittent Porphyria Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Acute Intermittent Porphyria Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2024-2033) & (US$ Million)
Table 46. Dahaner Company Detail
Table 47. Dahaner Business Overview
Table 48. Dahaner Acute Intermittent Porphyria Product
Table 49. Dahaner Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 50. Dahaner Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Acute Intermittent Porphyria Product
Table 54. Roche Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Bio-Rad Laboratories Company Detail
Table 57. Bio-Rad Laboratories Business Overview
Table 58. Bio-Rad Laboratories Acute Intermittent Porphyria Product
Table 59. Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 60. Bio-Rad Laboratories Recent Development
Table 61. Siemens Company Detail
Table 62. Siemens Business Overview
Table 63. Siemens Acute Intermittent Porphyria Product
Table 64. Siemens Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 65. Siemens Recent Development
Table 66. ARKRAY Company Detail
Table 67. ARKRAY Business Overview
Table 68. ARKRAY Acute Intermittent Porphyria Product
Table 69. ARKRAY Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 70. ARKRAY Recent Development
Table 71. Sysmex Corporation Company Detail
Table 72. Sysmex Corporation Business Overview
Table 73. Sysmex Corporation Acute Intermittent Porphyria Product
Table 74. Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 75. Sysmex Corporation Recent Development
Table 76. ACON Laboratories Company Detail
Table 77. ACON Laboratories Business Overview
Table 78. ACON Laboratories Acute Intermittent Porphyria Product
Table 79. ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2018-2023) & (US$ Million)
Table 80. ACON Laboratories Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Intermittent Porphyria Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acute Intermittent Porphyria Market Share by Type: 2022 VS 2033
Figure 3. Gonadotropin-Releasing Hormone Analogues Features
Figure 4. Prophylactic Hematin Infusions Features
Figure 5. Global Acute Intermittent Porphyria Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Acute Intermittent Porphyria Market Share by Application: 2022 VS 2033
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Research Centers Case Studies
Figure 9. Acute Intermittent Porphyria Report Years Considered
Figure 10. Global Acute Intermittent Porphyria Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Acute Intermittent Porphyria Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Acute Intermittent Porphyria Market Share by Region: 2022 VS 2033
Figure 13. Global Acute Intermittent Porphyria Market Share by Players in 2022
Figure 14. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Acute Intermittent Porphyria Revenue in 2022
Figure 16. North America Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Acute Intermittent Porphyria Market Share by Country (2018-2033)
Figure 18. United States Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Acute Intermittent Porphyria Market Share by Country (2018-2033)
Figure 22. Germany Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Acute Intermittent Porphyria Market Share by Region (2018-2033)
Figure 30. China Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Acute Intermittent Porphyria Market Share by Country (2018-2033)
Figure 38. Mexico Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Acute Intermittent Porphyria Market Share by Country (2018-2033)
Figure 42. Turkey Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Acute Intermittent Porphyria Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Dahaner Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 45. Roche Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 47. Siemens Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 48. ARKRAY Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 49. Sysmex Corporation Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 50. ACON Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed